XRCC5 and Miyoshi myopathy: Consistent with this hypothesis, levels of certain DNA repair proteins may be prognostic biomarkers in patients with MM, e.g. XRCC5 (Ku80), required for DNA double-strand break repair, has been associated with significantly worse survival.11